Products - MOLECULAR DIAGNOSTIC

REALQUALITY RQ-HHV 7

 

Description

REALQUALITY RQ-HHV 7 is a diagnostic CE-IVD kit for the identification and quantification of the DNA of Human Herpesvirus type 7 (HHV 7) by Real time PCR

Peculiarity

  • The device is validated on DNA extracted from various samples types
  • The assay requires only 5 µL of DNA extracted
  • If used in combination with the REALQUALITY RQ-HHV 7 STANDARD, it allows the quantification of the viral DNA present in the sample 
  • The assay shares the same thermal profile of the REALQUALITY Infectious diseases kits
  • Validated on main Real time PCR instruments
  • The assay includes dUTP/UNG system for preventing carry-over contamination and a fluorescence normalizer
  • The automatic format of the assay can be used on GENEQUALITY X120 platform
  • Easy interpretation of results with AB Genius Report software
 
Kit content
  • Ready-to-use reagents for Real time PCR 
  • Internal control (amplification of beta-globin gene - BG)
  • Positive control (DNA containing fragments of the HHV 7 genome and the BG gene)
 
For further information
 
Human Herpes virus 7 (HHV 7) is a herpetic virus that was first isolated in 1990, with a tropism predominantly for T cells. Immediately after its discovery it was associated with some cases of exanthema subitum, or sixth disease, a childhood illness usually caused by HHV 6. As with the latter, primary infection occurs in the paediatric population and progresses benignly.
Although not yet fully understood, reactivation in immunocompromised patients has been associated with pneumonia in lung transplant recipients, general dysfunctioning of the transplanted organ, meningitis and encephalitis. HHV 7 seems to be associated with Gilbert pityriasis rosea, a form of dermatitis with exanthematous manifestation that occurs in individuals aged 10 to 35 years.
 
Why use Real time PCR assay for HHV 7?
 
The Real time PCR assay is certainly the fastest, most specific method for the identification of HHV 7. It makes it possible to exclude the possibility of infection by other pathogens with similar clinical manifestations, especially in cases of immunocompromised patients or patients with transplants.
 
 

This product uses technology patented by Biosearch Technologies, licensed for use in Human Molecular Diagnostic applications.

Files to download:

Ordering Information

Code Description Package
RQ-19-4M REALQUALITY RQ-HHV 7 50 tests
RQ-19-6M REALQUALITY RQ-HHV 7 100 tests
RQ-19-4A REALQUALITY RQ-HHV 7 - Automatic format 50 tests
RQ-19-6A REALQUALITY RQ-HHV 7 - Automatic format 100 tests